Search

for
Search:

Did you mean PDE4 inhibitors?

GlossaryPDE4 inhibitors

block an enzyme to reduce inflammation and immune responses

PDE4 inhibitors, also known as Phosphodiesterase 4 inhibitors or PDE4i, are a class of drugs that block the enzyme phosphodiesterase 4. This enzyme is involved in breaking down cyclic adenosine monophosphate (cAMP), a molecule that plays a crucial role in regulating inflammation and immune responses. By inhibiting PDE4, these drugs can help reduce inflammation and are used to treat conditions like psoriasis, chronic obstructive pulmonary disease (COPD), and certain types of alopecia.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 294 results

Systematic Review of Newer Agents for the Management of Alopecia Areata in Adults: Janus Kinase Inhibitors, Biologics and Phosphodiesterase-4 Inhibitors

research Systematic Review of Newer Agents for the Management of Alopecia Areata in Adults: Janus Kinase Inhibitors, Biologics and Phosphodiesterase-4 Inhibitors

12 citations, December 2022 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

research Apremilast Treatment of Atopic Dermatitis and Other Chronic Eczematous Dermatoses

31 citations, July 2017 in “Journal of the American Academy of Dermatology”

Apremilast improved symptoms in patients with severe skin conditions.

Targeting Anti-Inflammatory Immunonanocarriers to Human and Murine Neutrophils via Ly6 Antigen for Psoriasiform Dermatitis Alleviation

research Targeting Anti-Inflammatory Immunonanocarriers to Human and Murine Neutrophils via Ly6 Antigen for Psoriasiform Dermatitis Alleviation

April 2023 in “Journal of Investigative Dermatology”

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

research Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available Literature

1 citations, September 2022 in “Nepal journal of dermatology, venereology & leprology”

Apremilast shows promise for several skin conditions but needs more research.

research 22-Year-Old Male with Several Discrete Patches of Hair Loss

January 2022 in “Clinical Cases in Dermatology”

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

View more "pde-4 inhibitor" in research →

Community Join

1 / 1 results

community Scalp tension and thickness of the galea aponeurotica, inflammation and potential treatment pathways

in Research/Science 2 years ago

Scalp tension potentially affecting hair loss, and potential treatments for male pattern baldness such as Minoxidil, Finasteride and RU58841. Evidence from a study was discussed which suggests that the cause of MPB lies within the follicle itself and is not dependent on its surrounding environment.